Results 181 to 190 of about 35,241 (222)

Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma.

Cancer Discovery, 2017
L. Goyal, Supriya K. Saha, Leah Y. Liu, G. Siravegna, I. Leshchiner, Leanne G Ahronian, J. Lennerz, P. Vu, V. Deshpande, A. Kambadakone, Benedetta Mussolin, Stephanie Reyes, L. Henderson, Jiaoyuan E Sun, E. Seventer, Joseph M Gurski, Sabrina Baltschukat, Barbara Schacher-Engstler, Louise Barys, C. Stamm, P. Furet, D. Ryan, J. Stone, A. Iafrate, Gaddy Getz, Gaddy Getz, Diana Graus Porta, R. Tiedt, A. Bardelli, D. Juric, R. Corcoran, N. Bardeesy, A. Zhu   +32 more
semanticscholar   +1 more source

Abrogation of FGFR signaling blocks β-catenin-induced adrenocortical hyperplasia and aldosterone production. [PDF]

JCI Insight
Chortis V, Kariyawasam D, Berber M, Guagliardo NA, Leng S, Haykir B, Ribeiro C, Shah MS, Pignatti E, Jorgensen B, Gaston L, Barrett PQ, Carlone DL, Borges KS, Breault DT.   +14 more
europepmc   +1 more source

FGF10 ameliorates epileptic seizures and related cognitive dysfunction via the FGFR2/CALB1 signaling pathway. [PDF]

J Transl Med
Zhao L, Chen S, Jin X, Xiao Y, Zhang X, Lin Y, Liang C, Xu H.   +7 more
europepmc   +1 more source

Locoregional gemcitabine plus surufatinib and camrelizumab in FGFR2-non-altered intrahepatic cholangiocarcinoma. [PDF]

Cell Rep Med
Guo B, Fan Y, Li D, Xia F, Luo C, Zhu J, Wu Y, Zhu Z, Xiang S, Liu E, Zhang W.   +10 more
europepmc   +1 more source

FGFR2 expression relates to subtype-specific tumour microenvironment (TIME) during luminal breast cancer evolution. [PDF]

Front Oncol
Sołek J, Zielińska A, Kordek R, Romańska H, Braun M.   +4 more
europepmc   +1 more source

Outcome of Metastatic Biliary Tract Cancer Harbouring <i>IDH1</i> or <i>FGFR2</i> Alterations: A Retrospective Observational Real-World Study from a French Cohort. [PDF]

J Clin Med
Barbe-Richaud JB, Moinard-Butot F, Cotton M, Bigot C, Rivière P, Belletier C, Pencreach E, Karouby D, Chiappa P, Eberst L, Kurtz JE, Ben Abdelghani M.   +11 more
europepmc   +1 more source

Recurrent FGFR2 and PIK3CA Mutations in Sialoblastoma. [PDF]

Head Neck Pathol
Koo SC, Ma J, Tran QT, Alaggio R, Stracuzzi A, Chou PM, Wilkins BJ, Orr BA, Malik F.   +8 more
europepmc   +1 more source

Correction to: The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects. [PDF]

Hum Mol Genet
europepmc   +1 more source

Reflex somatic testing for the detection of FGFR alterations in urinary tract carcinomas: A dual-institutional experience. [PDF]

Am J Clin Pathol
Nguyen NJ, Olkhov-Mitsel E, Craddock KJ, Flood TA, Downes MR.   +4 more
europepmc   +1 more source

Pharmacologic inhibition of IRE1α-dependent decay protects alveolar epithelial identity and prevents pulmonary fibrosis in mice. [PDF]

J Clin Invest
Auyeung VC, Steinberg TL, Olivier A, Suzuki L, Moreno ME, Khan IS, Downey MS, Thamsen M, Guo L, Maly DJ, Backes BJ, Sheppard D, Papa FR.   +12 more
europepmc   +1 more source